VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Dual antiplatelet treatment
Preclinical
Small molecule
X
Xueli Cai
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Stent Implantation
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Stent Implantation
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
Stent Implantation
1 trial
Stent Implantation Versus Balloon Dilation for Acute Anterior Circulation Tandem Occlusion
Unknown status
·
X
Xueli Cai
·
N/A
·
NCT05902000
·
222 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Dual antiplatelet treatment. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Dual antiplatelet treatment compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Dual antiplatelet treatment. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Xueli Cai company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
X
Xueli Cai
Related News